21 May 2012 08:23 [Source: ICIS news]
SINGAPORE (ICIS)--DSM has commenced its previously announced cash tender offer for all outstanding shares of US-based biomedical firm Kensey Nash at $38.50 (€30) per share, or about $360m, the Dutch specialty chemicals firm said on Monday.
The tender offer is scheduled to expire on 18 June this year, unless the offer is extended, the company said in a statement.
Kensey Nash is mainly focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology, it said.
($1 = €0.78)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections